Cargando…
Investigation of Newly Diagnosed Drug-Naive Patients with Systemic Autoimmune Diseases Revealed the Cleaved Peptide Tyrosine Tyrosine (PYY 3-36) as a Specific Plasma Biomarker of Rheumatoid Arthritis
There is a current imperative to reveal more precisely the molecular pathways of early onset of systemic autoimmune diseases (SADs). The investigation of newly diagnosed drug-naive SAD patients might contribute to identify novel disease-specific and prognostic markers. The multiplex analysis of 30 p...
Autores principales: | Balog, Jozsef A., Kemeny, Agnes, Puskas, Laszlo G., Burcsar, Szilard, Balog, Attila, Szebeni, Gabor J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240466/ https://www.ncbi.nlm.nih.gov/pubmed/34239365 http://dx.doi.org/10.1155/2021/5523582 |
Ejemplares similares
-
Comparison of Homologous and Heterologous Booster SARS-CoV-2 Vaccination in Autoimmune Rheumatic and Musculoskeletal Patients
por: Honfi, Dániel, et al.
Publicado: (2022) -
Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study
por: Szebeni, Gábor J., et al.
Publicado: (2022) -
Immunoprofiling of Drosophila Hemocytes by Single-cell Mass Cytometry
por: Balog, József Á., et al.
Publicado: (2021) -
Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer
por: Szalontai, Klára, et al.
Publicado: (2021) -
Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2
por: Szabó, Enikő, et al.
Publicado: (2023)